Neurometabolic Imaging Lab
Neurometabolic Imaging Lab
In vivo Glx and Glu measurements from GABA-edited MRS at 3 T.
Diagnostic accuracy and added value of qualitative radiological review of (1) H-magnetic resonance spectroscopy in evaluation of childhood brain tumors.
Methodological consensus on clinical proton MRS of the brain: Review and recommendations.
Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD+ Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures.
Robust retrospective frequency and phase correction for single-voxel MR spectroscopy.
Short-acquisition-time JPRESS and its application to paediatric brain tumours.
Variation of T2 relaxation times in pediatric brain tumors and their effect on metabolite quantification.
Tissue metabolite profiles for the characterisation of paediatric cerebellar tumours.
Application of pattern recognition techniques for classification of pediatric brain tumors by in vivo 3T (1) H-MR spectroscopy-A multi-center study.
Glycine: a non-invasive imaging biomarker to aid magnetic resonance spectroscopy in the prediction of survival in paediatric brain tumours.
Neural changes associated with cerebellar tDCS studied using MR spectroscopy.
Quantitative Brain MRI in Congenital Adrenal Hyperplasia: In Vivo Assessment of the Cognitive and Structural Impact of Steroid Hormones.
Metabolic profiling of the three neural derived embryonal pediatric tumors retinoblastoma, neuroblastoma and medulloblastoma, identifies distinct metabolic profiles.
Metabolite Levels in Paediatric Brain Tumours Correlate with Histological Features.
Multiclass imbalance learning: Improving classification of pediatric brain tumors from magnetic resonance spectroscopy.
Influence of macromolecule baseline on (1) H MR spectroscopic imaging reproducibility.
Metabolite profiling in retinoblastoma identifies novel clinicopathological subgroups.
Sensitivity encoding for fast (1) H MR spectroscopic imaging water reference acquisition.
Multi-centre reproducibility of diffusion MRI parameters for clinical sequences in the brain.
MRS water resonance frequency in childhood brain tumours: a novel potential biomarker of temperature and tumour environment.
Noninvasive detection of glutamate predicts survival in pediatric medulloblastoma.
Clinical protocols for ³¹P MRS of the brain and their use in evaluating optic pathway gliomas in children.
Diagnosing relapse in children's brain tumors using metabolite profiles.
Classification of single-voxel 1H spectra of childhood cerebellar tumors using LCModel and whole tissue representations.
Increased unsaturation of lipids in cytoplasmic lipid droplets in DAOY cancer cells in response to cisplatin treatment.
Accurate classification of childhood brain tumours by in vivo ¹H MRS - a multi-centre study.
Magnetic resonance spectroscopy metabolite profiles predict survival in paediatric brain tumours.
The size of cytoplasmic lipid droplets varies between tumour cell lines of the nervous system: a 1H NMR spectroscopy study.
Lipid biomarkers of glioma cell growth arrest and cell death detected by 1 H magic angle spinning MRS.
The lipid composition of isolated cytoplasmic lipid droplets from a human cancer cell line, BE(2)M17.
A hybrid method of application of independent component analysis to in vivo 1H MR spectra of childhood brain tumours.
Recapitulation of tumor heterogeneity and molecular signatures in a 3D brain cancer model with decreased sensitivity to histone deacetylase inhibition.
In vitro metabonomic study detects increases in UDP-GlcNAc and UDP-GalNAc, as early phase markers of cisplatin treatment response in brain tumor cells.
1H magnetic resonance spectroscopy metabolites as biomarkers for cell cycle arrest and cell death in rat glioma cells.
MR spectroscopy-based brain metabolite profiling in propionic acidaemia: metabolic changes in the basal ganglia during acute decompensation and effect of liver transplantation.
A constrained least-squares approach to the automated quantitation of in vivo ¹H magnetic resonance spectroscopy data.
A comparison between simulated and experimental basis sets for assessing short-TE in vivo ¹H MRS data at 1.5 T.
A quantitative comparison of metabolite signals as detected by in vivo MRS with ex vivo 1H HR-MAS for childhood brain tumours.
High resolution magic angle spinning 1H NMR of childhood brain and nervous system tumours.
1H MRS identifies specific metabolite profiles associated with MYCN-amplified and non-amplified tumour subtypes of neuroblastoma cell lines.
An algorithm for the automated quantitation of metabolites in in vitro NMR signals.